We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

574 hedge funds and large institutions have $3.14B invested in iShares US Medical Devices ETF in 2021 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 218 increasing their positions, 189 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 43

21% more funds holding in top 10

Funds holding in top 10: 1923 (+4)

15% more repeat investments, than reductions

Existing positions increased: 218 | Existing positions reduced: 189

9% more capital invested

Capital invested by funds: $2.87B → $3.14B (+$266M)

3% more funds holding

Funds holding: 559574 (+15)

6% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.1M

200.14% less ownership

Funds ownership: 237.4%37.27% (-200%)

Holders
574
Holders Change
+15
Holders Change %
+2.68%
% of All Funds
10.05%
Holding in Top 10
23
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+21.05%
% of All Funds
0.4%
New
66
Increased
218
Reduced
189
Closed
43
Calls
$17.2M
Puts
$16.1M
Net Calls
+$1.01M
Net Calls Change
+$6.94M
Name Holding Trade Value Shares
Change
Change in
Stake
MA
376
MUFG Americas
New York
$407K
FFWM
377
Future Financial Wealth Management
Ohio
$405K -$358K -5,605 -83%
SFI
378
SPC Financial Inc
Maryland
$400K -$383 -6 -0.1%
VFM
379
Vivid Financial Management
California
$392K -$499K -7,824 -56%
LWM
380
Liberty Wealth Management
California
$391K -$274K -4,297 -41%
IA
381
IFG Advisory
Georgia
$391K +$54.5K +854 +16%
KPCM
382
Kings Point Capital Management
New York
$388K +$6.06K +95 +2%
MSA
383
Marino Stram & Associates
Massachusetts
$388K +$394K +6,181 New
PP
384
Patten & Patten
Tennessee
$386K +$8.04K +126 +2%
AWA
385
Acorn Wealth Advisors
Michigan
$384K -$42K -659 -10%
COF
386
Capital One Financial
Virginia
$384K
AWM
387
Avitas Wealth Management
California
$383K -$64 -1 -0%
HWM
388
HFR Wealth Management
New York
$377K
IFO
389
Independent Family Office
New York
$377K
SFM
390
Signet Financial Management
New Jersey
$377K +$384K +6,011 New
Susquehanna International Group
391
Susquehanna International Group
Pennsylvania
$374K +$380K +5,951 New
TW
392
TrinityPoint Wealth
Connecticut
$374K +$380K +5,958 New
CPC
393
Cookson Peirce & Co
Pennsylvania
$373K +$2.94K +46 +0.8%
Wolverine Trading
394
Wolverine Trading
Illinois
$367K -$671K -10,519 -65%
AIP
395
Almanack Investment Partners
Pennsylvania
$363K -$766 -12 -0.2%
BOPW
396
Brandywine Oak Private Wealth
Pennsylvania
$355K -$17.2K -270 -5%
FHA
397
Flagship Harbor Advisors
Massachusetts
$350K -$309K -4,845 -83%
ACM
398
Advisors Capital Management
New Jersey
$339K -$191 -3 -0.1%
BFO
399
Biltmore Family Office
North Carolina
$339K +$172K +2,700 +100%
HAS
400
HBW Advisory Services
California
$334K +$31.1K +488 +10%

IHI Hedge Fund Activity: Q3 2021 in Review

574 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2021, worth a combined $3.14B — up 9.3% from $2.87B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new IHI positions and 43 closed out — a net gain of 23 holders — while 218 added to existing stakes and 189 trimmed.

The largest buyer was Harel Insurance Investments & Financial Services, adding an estimated $45.5M. The largest seller was TD Asset Management, cutting an estimated $128M.

  • 574 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2021, up from 559 in Q2 2021.
  • Funds reported $3.14B of iShares US Medical Devices ETF stock for Q3 2021, up 9.3% quarter-over-quarter.
  • 66 funds opened new iShares US Medical Devices ETF positions in Q3 2021 and 43 closed out, a net change of +23 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2021 was Harel Insurance Investments & Financial Services, an estimated $45.5M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2021 was TD Asset Management, an estimated $128M sold.

Based on aggregated 13F filings for Q3 2021.